| WKN: | A1X3W0 |
| ISIN: | DE000A1X3W00 |
| Land: | Deutschland |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Medigene-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 11. Dezember 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2015 | 3,73 | 8,65 | 132,03% |
| 2 | 2003 | 15,84 | 23,80 | 50,25% |
| 3 | 2004 | 23,80 | 34,60 | 45,38% |
| 4 | 2016 | 8,65 | 11,86 | 37,05% |
| 5 | 2017 | 11,86 | 12,83 | 8,23% |
| 6 | 2014 | 3,46 | 3,73 | 7,71% |
| 7 | 2012 | 3,84 | 3,96 | 3,13% |
| 8 | 2005 | 34,60 | 33,52 | -3,12% |
| 9 | 2020 | 4,02 | 3,54 | -12,11% |
| 10 | 2013 | 3,96 | 3,46 | -12,60% |
| 11 | 2006 | 33,52 | 28,00 | -16,47% |
| 12 | 2009 | 17,28 | 14,40 | -16,67% |
| 13 | 2021 | 3,54 | 2,89 | -18,25% |
| 14 | 2008 | 21,44 | 17,28 | -19,40% |
| 15 | 2023 | 2,05 | 1,58 | -22,93% |
| 16 | 2007 | 28,00 | 21,44 | -23,43% |
| 17 | 2022 | 2,89 | 2,05 | -29,07% |
| 18 | 2024 | 1,58 | 1,02 | -35,57% |
| 19 | 2018 | 12,83 | 7,44 | -42,05% |
| 20 | 2010 | 14,40 | 7,98 | -44,56% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2025 | 1,02 | 0,02 | -97,64% |
| 2 | 2002 | 84,80 | 15,84 | -81,32% |
| 3 | 2001 | 294,00 | 84,80 | -71,16% |
| 4 | 2011 | 7,98 | 3,84 | -51,90% |
| 5 | 2019 | 7,44 | 4,02 | -45,90% |
| 6 | 2010 | 14,40 | 7,98 | -44,56% |
| 7 | 2018 | 12,83 | 7,44 | -42,05% |
| 8 | 2024 | 1,58 | 1,02 | -35,57% |
| 9 | 2022 | 2,89 | 2,05 | -29,07% |
| 10 | 2007 | 28,00 | 21,44 | -23,43% |
| 11 | 2023 | 2,05 | 1,58 | -22,93% |
| 12 | 2008 | 21,44 | 17,28 | -19,40% |
| 13 | 2021 | 3,54 | 2,89 | -18,25% |
| 14 | 2009 | 17,28 | 14,40 | -16,67% |
| 15 | 2006 | 33,52 | 28,00 | -16,47% |
| 16 | 2013 | 3,96 | 3,46 | -12,60% |
| 17 | 2020 | 4,02 | 3,54 | -12,11% |
| 18 | 2005 | 34,60 | 33,52 | -3,12% |
| 19 | 2012 | 3,84 | 3,96 | 3,13% |
| 20 | 2014 | 3,46 | 3,73 | 7,71% |